FindTrial
Sign In

Effect of Flavonoid and Ursolic Acid supplements on the Upper Respiratory Tract Infections among adults in north India: A randomized controlled trial

Effect of Flavonoid and Ursolic Acid based supplement on the incidence and severity of Upper Respiratory Tract Infections among adults in north India: A pilot multi-centric, multi-arm, triple-blinded, randomized placebo-controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030537
Enrollment
90
Registered
2021-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J06- Acute upper respiratory infections

Interventions

Intervention1: RESPICARE capsule: RESPICARE capsule (350 mg of QUERCETIN+300mg of Rosemary Extract+100mg Vitamin C) two times a day for 30 days to patient with URTI+ Placebo (Maize powder) two times d

Sponsors

Chemical Resources CHERESO
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals/Persons aged >=18 years, attending the hospital/clinic OPD, diagnosed with URTI and provided consent for the study. All healthy family contacts (>=18 years) of patients with URTI will be recruited for providing prophylactic supplement.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Incidence of URTIs among the patients Incidence of URTIs among the healthy household/family members Duration and severity of the disease among the participants with URTI Days missed from work college by the participants with URTITimepoint: 0 1 3 months—

Secondary

MeasureTime frame
Adverse effects of flavonoid supplementation Compliance to interventionTimepoint: 0 1 3 months—

Countries

India

Contacts

Public ContactKathirvel S

Post Graduate Institute of Medical Education and Research

selvkathir@gmail.com09585395395

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026